Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

2,076.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 2,340.00
  • 52 Week Low: 1,772.00
  • Currency: UK Pounds
  • Shares Issued: 234.72m
  • Volume: 390,743
  • Market Cap: £4,872.78m
  • RiskGrade: 125
  • Beta: 0.00

Regulatory News

Director/PDMR Shareholding 20-May-2025 14:49 RNS
Medium-term Group guidance ahead of US site visit 15-May-2025 12:00 RNS
Director/PDMR Shareholding 08-May-2025 16:35 RNS
S&P upgrades Hikma to ‘BBB’ 08-May-2025 10:48 RNS
Settlement agreement for Xyrem® US lawsuits 08-May-2025 08:21 RNS
Director/PDMR Shareholding 30-Apr-2025 13:21 RNS
Result of AGM 24-Apr-2025 15:55 RNS
Trading Statement 24-Apr-2025 07:00 RNS
Director/PDMR Shareholding 10-Apr-2025 14:36 RNS
Director/PDMR Shareholding 08-Apr-2025 13:47 RNS
Block listing Interim Review 01-Apr-2025 09:30 RNS
Annual Financial Report and Notice of AGM 19-Mar-2025 10:10 RNS
Director/PDMR Shareholding 04-Mar-2025 11:16 RNS
Final Results 26-Feb-2025 07:00 RNS
Notice of Results 10-Feb-2025 08:09 RNS
 
HTTP/1.1 200 OK Date: Sat, 24 May 2025 23:02:02 GMT Server: Apache Set-Cookie: splash_page_count=2; domain=digitallook.com; path=/ Set-Cookie: buffer=splash_page_count%3d1; domain=digitallook.com; path=/ Location: http://static.digitallook.com/maintenance.html Connection: close Transfer-Encoding: chunked Content-Type: text/html; charset=iso-8859-1 200 OK

OK

The document has moved here.